Abbott Laboratories (ETR:ABL)
129.16
+2.54 (2.01%)
Feb 21, 2025, 5:35 PM CET
Abbott Laboratories Revenue
In the year 2024, Abbott Laboratories had annual revenue of $41.95B USD with 4.59% growth. Abbott Laboratories had revenue of $10.97B in the quarter ending December 31, 2024, with 7.16% growth.
Revenue
$41.95B
Revenue Growth
+4.59%
P/S Ratio
n/a
Revenue / Employee
$367.98K
Employees
114,000
Market Cap
223.90B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 22.67B |
Merck KGaA | 20.96B |
Bayer Aktiengesellschaft | 46.74B |
Fresenius SE & Co. KGaA | 22.81B |
Sartorius Aktiengesellschaft | 3.38B |
Fresenius Medical Care AG | 19.24B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Abbott Laboratories News
- 1 day ago - Abbott Declares 405th Consecutive Quarterly Dividend - PRNewsWire
- 8 days ago - Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom - Benzinga
- 10 days ago - Rep. Emily Randall Has Sold Up to $165K Worth Of Abbott Laboratories Stock: Here's What You Should Know - Benzinga
- 11 days ago - Looking Into Abbott Laboratories's Recent Short Interest - Benzinga
- 15 days ago - Why We Chose Abbott Labs Stock Amid Tariff And DeepSeek Volatility - Investor's Business Daily
- 15 days ago - Delhivery appoints Vani Venkatesh as Chief Business Officer - Business Upturn
- 16 days ago - Here are the best performing dividend aristocrats stocks in 2025 - Invezz
- 18 days ago - Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care - PRNewsWire